ESPR  220916C00010000

Sold all ESPR $10 Calls

This member connected a brokerage account and is sharing trades and portfolio performance with the community. 

Public Portfolio

Zachary Rapp

Bought ESPR $10 Calls

Sold 33% of ESPR $10 Calls

Sold 25% of ESPR $10 Calls

ESPR  220121C00007500

Bought ESPR $7.50 Calls

KiloG

esperion therapeutics, inc. is a pharmaceutical company focused on developing and commercializing first-in-class, oral, ldl-c lowering therapies for the treatment of patients with hypercholesterolemia. etc-1002, the company's lead product candidate, is an 

Esperion Therapeutics, Inc.

Bought <1% more ESPR

Paul

New position in ESPR

Sold 90% of ESPR

Ashish Mehta

Sold 39% of ESPR

Sold 20% of ESPR

Sold 17% of ESPR

Sold 53% of ESPR

Bought 10% more ESPR

Bought 11% more ESPR

Bought 19% more ESPR

Bought 13% more ESPR

Bought 15% more ESPR

Bought 18% more ESPR

Bought 22% more ESPR

Bought 28% more ESPR

Bought 38% more ESPR

Bought 61% more ESPR

Bought 147% more ESPR

Sold 42% of ESPR